Telix Pharmaceuticals’ quarterly revenue exceeds AU$200M
Telix Pharmaceuticals (ASX:TLX) has revealed its quarterly revenues, reaffirming its full-year 2024…
Telix Pharmaceuticals Limited (ASX:TLX)
About Telix Pharmaceuticals Limited
Key Information
TLX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/11/2024 | Price Sensitive PS Presentation to Accompany FAP-Targeting Acquisition | 1.33MB | 4.2K |
| 19/11/2024 | Price Sensitive PS Telix Adds FAP-Targeting Theranostic Candidates to Pipeline | 140.37KB | 577 |
| 14/11/2024 | Securities Dealing Policy - Updated | 256.48KB | 368 |
| 14/11/2024 | Telix ADSs Commence Trading on Nasdaq | 123.08KB | 3.8K |
| 04/11/2024 | Price Sensitive PS CMS payment improvement decision for radiopharma diagnostics | 143.55KB | 5.9K |
| 24/10/2024 | Price Sensitive PS FDA accepts NDA and grants priority review for Pixclara | 148.42KB | 13K |
| 23/10/2024 | Pending Release of Shares from Voluntary Escrow | 138.97KB | 581 |
| 18/10/2024 | Price Sensitive PS Telix Files Form 20-F Registration Statement for Nasdaq ADS | 171.46KB | 17K |